Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Opko Health Inc. (OPK)

Pharmaceutical Preparations

https://www.opko.com

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

4400 BISCAYNE BLVD.
MIAMI, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/02/1995

Market Cap

1,084,419,680

Shares Outstanding

773,060,000

Weighted SO

773,056,533

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

CDNA --.--%

CSTL --.--%

TWST --.--%

BDSX --.--%

NTRA --.--%

FLGT --.--%

NVTA --.--%

ILMN --.--%

TTOO --.--%

Beta

1.6500

Last Div

0.0000

Range

0.85-1.9

Chg

-0.0250

Avg Vol

3412566

Mkt Cap

1084419680

Exch

NASDAQ

Country

US

Phone

305 575 4100

DCF Diff

0.5367

DCF

1.7967

Div Yield

0.0000

P/S

1.5138

EV Multiple

-7.6628

P/FV

0.7770

Div Yield %

0.0000

P/E

-4.4588

PEG

-0.7032

Payout

0.0000

Current Ratio

1.6305

Quick Ratio

1.3565

Cash Ratio

0.1848

DSO

59.1110

DIO

36.9872

Op Cycle

96.0982

DPO

50.5694

CCC

45.5288

Gross Margin

0.1714

Op Margin

-0.3722

Pretax Margin

-0.3415

Net Margin

-0.3394

Eff Tax Rate

0.0063

ROA

-0.1228

ROE

-0.1774

ROCE

-0.1515

NI/EBT

0.9938

EBT/EBIT

0.9176

EBIT/Rev

-0.3722

Debt Ratio

0.1088

D/E

0.1543

LT Debt/Cap

0.1140

Total Debt/Cap

0.1337

Int Coverage

627.3929

CF/Debt

-0.3120

Equity Multi

1.4189

Rec Turnover

6.1748

Pay Turnover

7.2178

Inv Turnover

9.8683

FA Turnover

5.5797

Asset Turnover

0.3618

OCF/Share

-0.0964

FCF/Share

-0.1235

Cash/Share

0.0582

OCF/Sales

-0.0938

FCF/OCF

1.2811

CF Coverage

-0.3120

ST Coverage

-1.8814

CapEx Coverage

-3.5576

Div&CapEx Cov

-3.5576

P/BV

0.7770

P/B

0.7770

P/S

1.5138

P/E

-4.4588

P/FCF

-12.5991

P/OCF

-16.1368

P/CF

-16.1368

PEG

-0.7032

P/S

1.5138

EV Multiple

-7.6628

P/FV

0.7770

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 02, 05:00 AVTL successfully completed IPO GlobeNewswire Inc. Feb 19, 05:58 Vopak announces share buyback program to return up to EUR 100 million to shareholders GlobeNewswire Inc. Aug 04, 23:00 The Northern Territory Government and Vopak sign MoU to cooperate on common user CO2 infrastructure hub in Australia GlobeNewswire Inc. Jan 04, 23:31 OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 GlobeNewswire Inc. Jan 04, 23:31 OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 GlobeNewswire Inc. Jan 04, 23:31 OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 GlobeNewswire Inc. Jan 04, 23:31 OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 GlobeNewswire Inc. Jan 04, 23:31 OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 GlobeNewswire Inc. Jan 04, 23:31 OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 GlobeNewswire Inc. Jan 03, 17:05 OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029 The Motley Fool Nov 07, 01:00 Opko Health (OPK) Q3 2023 Earnings Call Transcript The Motley Fool Nov 07, 01:00 Opko Health (OPK) Q3 2023 Earnings Call Transcript Zacks Investment Research Nov 06, 19:30 OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks Investment Research Nov 06, 19:30 OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Benzinga Nov 06, 13:35 Stocks Fight To Extend Winning Streak, Treasury Yields Rise: What's Driving Markets Monday? GlobeNewswire Inc. Nov 02, 10:00 New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Revenue Product Segmentation